Corcept Therapeutics Inc (CORT)

5.80
NASDAQ : Health Care
Prev Close 5.86
Day Low/High 5.78 / 5.91
52 Wk Low/High 3.22 / 6.33
Avg Volume 370.70K
Exchange NASDAQ
Shares Outstanding 109.80M
Market Cap 643.41M
EPS -0.10
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Short Interest Increases 35.2% For CORT

Short Interest Increases 35.2% For CORT

The most recent short interest data has been released by the NASDAQ for the 12/31/2015 settlement date, which shows a 1,176,495 share increase in total short interest for Corcept Therapeutics Inc , to 4,521,614, an increase of 35.17% since 12/15/2015. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Insider Trading Alert - RT, CORT And LAYN Traded By Insiders

Insider Trading Alert - RT, CORT And LAYN Traded By Insiders

Stocks with insider trader activity include RT, CORT and LAYN

Insider Trading Alert - CORT, PANW And EQIX Traded By Insiders

Insider Trading Alert - CORT, PANW And EQIX Traded By Insiders

Stocks with insider trader activity include CORT, PANW and EQIX

Insider Trading Alert - SPLK, CMCT And CORT Traded By Insiders

Insider Trading Alert - SPLK, CMCT And CORT Traded By Insiders

Stocks with insider trader activity include SPLK, CMCT and CORT

First Week of CORT May 2016 Options Trading

First Week of CORT May 2016 Options Trading

Investors in Corcept Therapeutics Inc saw new options begin trading this week, for the May 2016 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 233 days until expiration the newly trading contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

First Week of October 16th Options Trading For Corcept Therapeutics (CORT)

First Week of October 16th Options Trading For Corcept Therapeutics (CORT)

Investors in Corcept Therapeutics Inc saw new options become available this week, for the October 16th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the CORT options chain for the new October 16th contracts and identified the following put contract of particular interest.

Exploring Potential Portfolio Additions

With 21% of the model portfolio in cash, a variety of names are on our radar.

3 Pharmaceutical Stocks to Sell Now

3 Pharmaceutical Stocks to Sell Now

Pharmaceutical companies face increased risks if they do not have enough new drugs in the pipeline to replace those with expiring patents.

Quant Picks: 3 Pharmaceutical Companies to Sell Right Now

Quant Picks: 3 Pharmaceutical Companies to Sell Right Now

Here are some of the worst companies TheStreet Quant Ratings says you should consider selling.

Interesting CORT Put And Call Options For February 2016

Interesting CORT Put And Call Options For February 2016

Investors in Corcept Therapeutics Inc saw new options become available this week, for the February 2016 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 241 days until expiration the newly available contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Fly Watch: Several Names That May Move Following ASCO Meeting

Fly Watch: Several Names That May Move Following ASCO Meeting

The American Society of Clinical Oncology, or ASCO, is holding the society's 51st annual meeting from May 29 to June 2 in Chicago, Illinois.

Corcept Therapeutics (CORT) Strong On High Relative Volume Today

Corcept Therapeutics (CORT) Strong On High Relative Volume Today

Trade-Ideas LLC identified Corcept Therapeutics (CORT) as a strong on high relative volume candidate

Cortendo AB Joins National Organization For Rare Disorders (NORD)® Corporate Council

Cortendo AB Joins National Organization For Rare Disorders (NORD)® Corporate Council

Leaders in Rare Disease Community Unite for National Cushing's Syndrome Awareness Day on April 8

Corcept Therapeutics (CORT) Is Weak On High Volume Today

Corcept Therapeutics (CORT) Is Weak On High Volume Today

Trade-Ideas LLC identified Corcept Therapeutics (CORT) as a weak on high relative volume candidate

5 Stocks to Trade for Big Breakout Gains

5 Stocks to Trade for Big Breakout Gains

These stocks look ready to break out and trade higher from current levels.

5 Stocks Ready to Break Out

5 Stocks Ready to Break Out

These stocks look poised to break out and trade higher from current levels.

Why Corcept Therapeutics (CORT) Is Plummeting Today

Why Corcept Therapeutics (CORT) Is Plummeting Today

Corcept Therapeutics (CORT) plummeted Wednesday after the company stopped a late-stage trial of its depression treatment drug Mifepristone after analysis determined it was unlikely to succeed.

First Week of November 22nd Options Trading For Corcept Therapeutics (CORT)

First Week of November 22nd Options Trading For Corcept Therapeutics (CORT)

Investors in Corcept Therapeutics Inc saw new options become available this week, for the November 22nd expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 236 days until expiration the newly available contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

5 Stocks Setting Up to Break Out

5 Stocks Setting Up to Break Out

These stocks look poised to break out and trade higher from current levels.

Behind The Success - Research Report On Corcept Therapeutics Inc. And Dyax Corp.

Behind The Success - Research Report On Corcept Therapeutics Inc. And Dyax Corp.

Biotech firms Corcept and Dyax have each risen to the occasion with their innovative solutions for unmet medical needs, both having gained substantial momentum as of late

3 Stocks Under $2 Spiking Higher

3 Stocks Under $2 Spiking Higher

Regardless of the reason behind it, when a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

Short Sellers Are More Bullish About These Hedge Fund Favorites

Short Sellers Are More Bullish About These Hedge Fund Favorites

Looking for stocks with bullish sentiment from both short sellers and hedge funds? If so, you will likely find this [...]

5 Stocks Insiders Are Snapping Up

5 Stocks Insiders Are Snapping Up

Insiders usually buy their own shares for one reason: They think the stock is a bargain and has tremendous upside.

Corcept Has Upside Following Drug Approval

Corcept Has Upside Following Drug Approval

FDA approved Corcept's Korlym for Cushing's syndrome.

7 Stocks Under $10 Moving Higher

7 Stocks Under $10 Moving Higher

When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

These Drugs Stocks Will Win FDA Approval

These Drugs Stocks Will Win FDA Approval

Contestants in TheStreet's FDA Drug-Approval Contest forecast their winners and losers.

Biotech Stock Mailbag: Corcept Therapeutics, Reader Retorts

Biotech Stock Mailbag: Corcept Therapeutics, Reader Retorts

Biotech columnist Adam Feuerstein answers readers' questions about health-care companies.